Androgen upregulates the palmitoylation of eIF3L in human prostate LNCaP cells

Background: Prostate cancer is the second leading cause of cancer-related deaths in Western countries. Most patients diagnosed with advanced prostate cancer can be treated with the main treatment: androgen deprivation therapy (ADT). The androgen receptor (AR) signaling axis plays a pivotal role in t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Cui, Luwei, Liu, Ming, Lai, Shicong, Hou, Huimin, Diao, Tongxiang, Zhang, Dalei, Wang, Miao, Zhang, Yaoguang, Wang, Jianye
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6556480/
https://ncbi.nlm.nih.gov/pubmed/31239713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S193480
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados